Search - tctmd.com

Displaying 101 - 120 of 248

Sort: Relevancy | Date

News Daily News

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

Michael O'Riordan

August 06, 2020

Podcast TCTMD Talking Points

COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3

August 05, 2020

AHA, Editors, and Cardiologists Ask: How Did ‘Racist’ Paper Made It to Print?

News Conference News

AHA, Editors, and Cardiologists Ask: How Did ‘Racist’ Paper Make It to Print?

Michael O'Riordan

August 05, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August

Todd Neale

August 01, 2020

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

Podcast TCTMD Talking Points

EVOLVE Short DAPT: 3-Month DAPT in Patients at High Bleeding Risk Treated with a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

July 22, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Higher Risk of HF After ACS for Women Previously on Beta-blockers

Michael O'Riordan

July 16, 2020

Podcast TCTMD Talking Points

#WomenAs1: The Battle for Gender Equality

July 15, 2020

News Daily News

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Michael O'Riordan

July 14, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Michael O'Riordan

July 08, 2020

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

Podcast TCTMD Talking Points

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

July 01, 2020

News Conference News EuroPCR 2020

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Michael O'Riordan

June 30, 2020

News Daily News

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

Yael L. Maxwell

June 30, 2020

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

News Conference News TVT 2020

Device Explants After TAVR Rare but Risky

Michael O'Riordan

June 24, 2020

Advertisement

New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts

COAPT Cost-effectiveness Analysis Plus Health-Status Outcomes in PARTNER 3

AHA, Editors, and Cardiologists Ask: How Did ‘Racist’ Paper Make It to Print?

COVID-19: TCTMD’s Daily Dispatch for August

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

EVOLVE Short DAPT: 3-Month DAPT in Patients at High Bleeding Risk Treated with a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Thrombus Burden Greater in STEMI Patients With COVID-19

Higher Risk of HF After ACS for Women Previously on Beta-blockers

#WomenAs1: The Battle for Gender Equality

Less MI, CV Death With Noninvasive Testing for Chest Pain: Observational Data

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Tirofiban Provides Better Platelet Inhibition Than Cangrelor in STEMI Patients

Short DAPT Reduces Bleeding With No Increase in MACE: Meta-analysis

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Device Explants After TAVR Rare but Risky

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content